Skip to content

Study of fungal infections in ICU patients to assess the incidence of fungal infections

Study of fungal infections in critically ill patients admitted in ICU trhough serological tests An observational study - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/01/100119
Enrollment
152
Registered
2026-01-01
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B377- Candidal sepsis

Interventions

Intervention1: Nil: Nil

Sponsors

Dr Vishaka Sreeja
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Pts admitted to ICU for more than 48 hours Patients clinically suspected of having invasive fungal infections. Informed consent obtained from the patient or legally authorized representative

Exclusion criteria

Exclusion criteria: Patients with only superficial fungal infections. Immunocompetent patients with no risk factors for IFIs. Patients who decline to provide consent or withdraw from the study.

Design outcomes

Primary

MeasureTime frame
To determine the incidence and spectrum of fungal infections in critically ill ICU patients.Timepoint: In patients admitted in ICU for more than 48 hours

Secondary

MeasureTime frame
To identify major risk factors associated with fungal infections in ICU settings.Timepoint: 15 days after the sample collection;To isolate & identify fungal species through blood cultures and serological assays like beta-D-glucan, galactomannan, & mannan.Timepoint: 15 days after the sample collection;To assess outcomes like mortality, ICU stay duration, in patients with fungal infectionsTimepoint: 4 weeks after the sample collection

Countries

India

Contacts

Public ContactProf Bikram Kumar Gupta

Institute of Medical Sciences BHU

bikramgupta03@gmail.com8400100128

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026